​

Funding Round

Post-IPO Equity - Day One Biopharmaceuticals

Post-IPO Equity - Day One Biopharmaceuticals

Investment Firm

Overview

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Announced Date

Jul 30, 2024

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorBraidwell
Participant InvestorAccess Biotechnology
Participant InvestorDeerfield
Participant InvestorFrazier Healthcare Partners
Participant InvestorWellington Management

Round Details and Background

Day One Biopharmaceuticals raised $175000000 on 2024-07-30 in Post-IPO Equity

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 10, 2021
Series B - Day One Biopharmaceuticals
11-130.0M
Jun 14, 2022
Post-IPO Equity - Day One Biopharmaceuticals
-172.5M
Jun 06, 2023
Post-IPO Equity - Day One Biopharmaceuticals
-150.0M
Jul 30, 2024
Post-IPO Equity - Day One Biopharmaceuticals
6-175.0M

Recent Activity

There is no recent news or activity for this profile.